Loading...
NEXGEL, Inc.
NXGL•NASDAQ
Healthcare
Medical - Instruments & Supplies
$2.36
$-0.02(-0.67%)
NEXGEL, Inc. (NXGL) Financial Performance & Income Statement Overview
Review NEXGEL, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
112.47%
↑ 112.47%
Operating Income Growth
-2.21%
↓ 2.21%
Net Income Growth
-3.93%
↓ 3.93%
Operating Cash Flow Growth
-19.50%
↓ 19.50%
Operating Margin
-33.83%
↓ 33.83%
Gross Margin
35.78%
↑ 35.78%
Net Profit Margin
-30.70%
↓ 30.70%
ROE
-63.38%
↓ 63.38%
ROIC
-43.70%
↓ 43.70%
NEXGEL, Inc. (NXGL) Income Statement & Financial Overview
Review NEXGEL, Inc.'s (NXGL) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $3.04M | $2.94M | $1.44M | $1.27M |
| Cost of Revenue | $2.26M | $1.66M | $1.03M | $1.02M |
| Gross Profit | $779000.00 | $1.28M | $410000.00 | $246000.00 |
| Gross Profit Ratio | $0.26 | $0.44 | $0.28 | $0.19 |
| R&D Expenses | $0.00 | $0.00 | $76000.00 | $2000.00 |
| SG&A Expenses | $1.53M | $2.07M | $1.39M | $1.11M |
| Operating Expenses | $1.62M | $2.07M | $1.46M | $1.12M |
| Total Costs & Expenses | $3.88M | $3.73M | $2.49M | $2.14M |
| Interest Income | $0.00 | $0.00 | $1000.00 | $0.00 |
| Interest Expense | $16000.00 | $20000.00 | $30000.00 | $15000.00 |
| Depreciation & Amortization | $150000.00 | $184000.00 | $86000.00 | $114000.00 |
| EBITDA | -$698000.00 | -$554000.00 | -$863000.00 | -$776000.00 |
| EBITDA Ratio | -$0.23 | -$0.19 | -$0.60 | -$0.61 |
| Operating Income | -$841000.00 | -$788000.00 | -$1.05M | -$871000.00 |
| Operating Income Ratio | -$0.28 | -$0.27 | -$0.73 | -$0.69 |
| Other Income/Expenses (Net) | $17000.00 | $34000.00 | $75000.00 | -$34000.00 |
| Income Before Tax | -$824000.00 | -$754000.00 | -$979000.00 | -$905000.00 |
| Income Before Tax Ratio | -$0.27 | -$0.26 | -$0.68 | -$0.71 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | -$52000.00 |
| Net Income | -$850000.00 | -$693000.00 | -$885000.00 | -$853000.00 |
| Net Income Ratio | -$0.28 | -$0.24 | -$0.61 | -$0.67 |
| EPS | -$0.13 | -$0.11 | -$0.14 | -$0.14 |
| Diluted EPS | -$0.13 | -$0.11 | -$0.14 | -$0.14 |
| Weighted Avg Shares Outstanding | $7.30M | $6.57M | $6.25M | $5.98M |
| Weighted Avg Shares Outstanding (Diluted) | $7.30M | $6.57M | $6.25M | $5.98M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan